Highlights Pulike Biological Engineering, Inc.

Equities

603566

CNE1000025N0

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-30 pm EDT			5-day change	1st Jan Change
16.95 ^CNY	+0.12%		-26.30%	-25.17%

Apr. 25	Pulike Biological Engineering, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 25	Pulike Biological Engineering, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pulike Biological Engineering, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Pulike Biological Engineering, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 25	CI
Tranche Update on Pulike Biological Engineering, Inc.'s Equity Buyback Plan announced on November 14, 2023.	Mar. 31	CI
Tranche Update on Pulike Biological Engineering, Inc.'s Equity Buyback Plan announced on November 14, 2023.	Jan. 02	CI
Pulike Biological Engineering, Inc. announces an Equity Buyback for CNY 120 million worth of its shares.	Nov. 13	CI
Pulike Biological Engineering, Inc. authorizes a Buyback Plan.	Nov. 12	CI
Pulike Biological Engineering, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-15	CI
Pulike Biological Engineering, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Pulike Biological Engineering, Inc. agreed to acquire Luoyang Lechong Health Technology Co., Ltd. from Shiji Mengbang Information Technology Co., Ltd. and Luoyang Jidi Biotechnology Center (Limited Partnership) for CNY 23.5 million.	23-06-30	CI
Pulike Biological Engineering Gets Certificate for Respiratory Drug for Chickens	23-05-08	MT
Pulike Biological Engineering, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Pulike Biological Engineering, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-25	CI
Frontier IP investee develops vaccine candidate for Streptococcus suis	22-12-02	AN
Pulike Biological Engineering, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25	CI
Pulike Biological Engineering Unit’s New Drug Wins Registration Certificate	22-10-19	MT
Pulike Biological Engineering, Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-09	CI
Pulike Biological Engineering, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI
Pulike Biological Engineering, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-28	CI
Pulike Biological Engineering, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-28	CI
Pulike Biological Engineering, Inc. Reports Earnings Results for the Half Year Ended June 30, 2021	21-07-29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Pulike Biological Engineering, Inc.

Equities

603566

CNE1000025N0

Highlights

Filters